Crossref
journal-article
Elsevier BV
Drug Discovery Today (78)
Authors
7
- Orazio Nicolotti (first)
- Emilio Benfenati (additional)
- Angelo Carotti (additional)
- Domenico Gadaleta (additional)
- Andrea Gissi (additional)
- Giuseppe Felice Mangiatordi (additional)
- Ettore Novellino (additional)
References
49
Referenced
77
{'year': '2012', 'series-title': 'The e-Book on QSAR and REACH: Theory, Guidance and Applications', 'key': '10.1016/j.drudis.2014.06.027_bib0005'}
/ The e-Book on QSAR and REACH: Theory, Guidance and Applications (2012){'key': '10.1016/j.drudis.2014.06.027_bib0010', 'first-page': '1', 'volume': '396', 'author': 'European Commission', 'year': '2006', 'journal-title': 'Off. J. Eur. Union Lett.'}
/ Off. J. Eur. Union Lett. by European Commission (2006){'key': '10.1016/j.drudis.2014.06.027_bib0015', 'first-page': '46', 'article-title': 'Recent developments in global regulatory framework in the chemical industry', 'volume': '57', 'author': 'Van Heerden', 'year': '2012', 'journal-title': 'Popul. Plast. Packag.'}
/ Popul. Plast. Packag. / Recent developments in global regulatory framework in the chemical industry by Van Heerden (2012)10.14573/altex.2009.3.187
/ ALTEX / Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals: a report by the Transatlantic Think Tank for Toxicology (T(4)) by Rovida (2009){'key': '10.1016/j.drudis.2014.06.027_bib0025', 'article-title': 'Exploratory toxicology as an integrated part of drug discovery. Part I: why and how', 'author': 'Hornberg', 'year': '2013', 'journal-title': 'Drug Discov. Today'}
/ Drug Discov. Today / Exploratory toxicology as an integrated part of drug discovery. Part I: why and how by Hornberg (2013){'key': '10.1016/j.drudis.2014.06.027_bib0030', 'first-page': '1', 'article-title': 'Regulation (EU) No 528/2012 of The European Parliament and of The Council of 22 May 2012 concerning the making available on the market and use of biocidal products', 'volume': '167', 'author': 'European Union', 'year': '2012', 'journal-title': 'Off. J. Eur. Union Lett.'}
/ Off. J. Eur. Union Lett. / Regulation (EU) No 528/2012 of The European Parliament and of The Council of 22 May 2012 concerning the making available on the market and use of biocidal products by European Union (2012)10.1002/qsar.200390007
/ QSAR Comb. Sci. / The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models by Tropsha (2003)10.1007/s10822-011-9495-0
/ J. Comput. Aided Mol. Des. / The inevitable QSAR renaissance by Cramer (2012)10.1016/j.yrtph.2013.06.002
/ Regul. Toxicol. Pharmacol. / Use of category approaches, read-across and (Q)SAR: general considerations by Patlewicz (2013)10.14573/altex.2013.1.019
/ ALTEX / Using toxicological evidence from QSAR models in practice by Benfenati (2013){'year': '2014', 'series-title': 'Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11', 'author': 'US EPA', 'key': '10.1016/j.drudis.2014.06.027_bib0055'}
/ Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11 by US EPA (2014)10.1080/15376510701857353
/ Toxicol. Mech. Methods / A hierarchical clustering methodology for the estimation of toxicity by Martin (2008)10.1177/026119291404200104
/ Altern. Lab. Anim. / The QSPR-THESAURUS: the online platform of the CADASTER project by Brandmaier (2014)10.1002/qsar.200810084
/ QSAR Comb. Sci. / Are the chemical structures in your QSAR correct? by Young (2008)10.1021/ci700443v
/ J. Chem. Inf. Model. / Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis by Zhu (2008)10.1021/ci800151m
/ J. Chem. Inf. Model. / Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection by Tetko (2008)10.1038/nrd1032
/ Nat. Rev. Drug Discov. / ADMET in silico modelling: towards prediction paradise? by van de Waterbeemd (2003)10.1016/S0169-409X(96)00423-1
/ Adv. Drug Deliv. Res. / Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings by Lipinski (1997)10.1038/nrd3367
/ Nat. Rev. Drug Discov. / Probing the links between in vitro potency, ADMET and physicochemical parameters by Gleeson (2011)10.1021/jm401564r
/ J. Med. Chem. / Discovery of Innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation by Abou-Gharbia (2014)10.1038/nchem.1243
/ Nat. Chem. / Quantifying the chemical beauty of drugs by Bickerton (2012){'key': '10.1016/j.drudis.2014.06.027_bib0110', 'series-title': 'Chemical Induction of Cancer. Modulation and Combination Effects', 'first-page': '1', 'article-title': 'Multifactor interaction network of carcinogenesis – a “Tour Guide”', 'author': 'Arcos', 'year': '1995'}
/ Chemical Induction of Cancer. Modulation and Combination Effects / Multifactor interaction network of carcinogenesis – a “Tour Guide” by Arcos (1995)10.1002/1097-0142(19840515)53:10<2034::AID-CNCR2820531005>3.0.CO;2-S
/ Cancer / The detection of environmental mutagens and potential carcinogens by Ames (1984)10.3109/10408444.2010.494175
/ Crit. Rev. Toxicol. / A review of the electrophilic reaction chemistry involved in covalent DNA binding by Enoch (2010)10.1021/cr300206t
/ Chem. Rev. / Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts by Benigni (2013)10.1021/ci300245q
/ J. Chem. Inf. Model. / ToxAlerts: a Web server of structural alerts for toxic chemicals and compounds with potential adverse reactions by Sushko (2012)10.1186/1752-153X-4-S1-S2
/ Chem. Cent. J. / An open source multistep model to predict mutagenicity from statistical analysis and relevant structural alerts by Ferrari (2010)10.1021/ci200091h
/ J. Chem. Inf. Model. / A comparison of different QSAR approaches to modeling CYP450 1A2 inhibition by Novotarskyi (2011)10.1016/j.drudis.2014.01.006
/ Drug Discov. Today / Addressing toxicity risk when designing and selecting compounds in early drug discovery by Segall (2014)10.1021/jm040835a
/ J. Med. Chem. / Derivation and validation of toxicophores for mutagenicity prediction by Kazius (2005)10.1002/qsar.200710118
/ QSAR Comb. Sci. / (Q)SARs for predicting effects relating to reproductive toxicity by Cronin (2008)10.1021/tx400226u
/ Chem. Res. Toxicol. / Framework for identifying chemicals with structural features associated with the potential to act as developmental or reproductive toxicants by Wu (2013)10.1021/ci9002409
/ J. Chem. Inf. Model. / Improving quantitative structure–activity relationships through multiobjective optimization by Nicolotti (2009)10.1016/j.jsbmb.2013.04.009
/ J. Steroid Biochem. Mol. Biol. / In silico methods in the discovery of endocrine disrupting chemicals by Vuorinen (2013)10.1016/j.drudis.2013.01.007
/ Drug Discov. Today / The holistic integration of virtual screening in drug discovery by Tanrikulu (2013)10.1371/journal.pone.0046958
/ PLoS ONE / Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action by Nashev (2012)10.1080/1062936X.2013.773375
/ SAR QSAR Environ. Res. / Hazard Evaluation Support System (HESS) for predicting repeated dose toxicity using toxicological categories by Sakuratani (2013)10.1021/ci8001974
/ J. Chem. Inf. Model. / Modeling oral rat chronic toxicity by Mazzatorta (2008)-
Gadaleta, D. et al. A k-NN algorithm for predicting the oral sub-chronic toxicity in the rat. ALTEX (in press), http://dx.doi.org/10.14573/altex.1405091.
(
10.14573/altex.1405091
) 10.1126/science.1154619
/ Science / Transforming environmental health protection by Collins (2008)10.1021/nn1013484
/ ACS Nano / Quantitative nanostructure–activity relationship modeling by Fourches (2010)10.1080/1062936X.2013.840679
/ SAR QSAR Environ. Res. / Evaluation criteria for the quality of published experimental data on nanomaterials and their usefulness for QSAR modelling by Lubinski (2013)10.1093/toxsci/kfh041
/ Toxicol. Sci. / Environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles by Dreher (2004)10.1002/smll.200900179
/ Small / Toward the development of ‘nano-QSARs’: advances and challenges by Puzyn (2009)10.1038/nnano.2011.10
/ Nat. Nanotechnol. / Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles by Puzyn (2011)10.1021/tx700392b
/ Chem. Res. Toxicol. / Identification of possible sources of nanotoxicity from carbon nanotubes inserted into membrane bilayers using membrane interaction quantitative structure–activity relationship analysis by Liu (2008)10.1021/mp800197v
/ Mol. Pharm. / Affinity of drugs and small biologically active molecules to carbon nanotubes: a pharmacodynamics and nanotoxicity factor? by Liu (2009)10.14573/altex.1305221
/ ALTEX / An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes by Gissi (2014)10.1177/026119291404200103
/ Altern. Lab. Anim. / Experimental and theoretical studies in the EU FP7 Marie Curie Initial Training Network Project, Environmental ChemOinformatics (ECO) by Tetko (2014)
Dates
Type | When |
---|---|
Created | 11 years, 1 month ago (July 3, 2014, 10:17 a.m.) |
Deposited | 6 years ago (Aug. 12, 2019, 3:22 a.m.) |
Indexed | 13 hours, 51 minutes ago (Aug. 23, 2025, 9:13 p.m.) |
Issued | 10 years, 9 months ago (Nov. 1, 2014) |
Published | 10 years, 9 months ago (Nov. 1, 2014) |
Published Print | 10 years, 9 months ago (Nov. 1, 2014) |
@article{Nicolotti_2014, title={REACH and in silico methods: an attractive opportunity for medicinal chemists}, volume={19}, ISSN={1359-6446}, url={http://dx.doi.org/10.1016/j.drudis.2014.06.027}, DOI={10.1016/j.drudis.2014.06.027}, number={11}, journal={Drug Discovery Today}, publisher={Elsevier BV}, author={Nicolotti, Orazio and Benfenati, Emilio and Carotti, Angelo and Gadaleta, Domenico and Gissi, Andrea and Mangiatordi, Giuseppe Felice and Novellino, Ettore}, year={2014}, month=nov, pages={1757–1768} }